DR. RAFFERTY & PARTNERS
BALLYCLARE GROUP PRACTICE, BALLYCLARE GROUP PRACTICE, BALLYCLARE HEALTH CENTRE, GEORGE AVENUE, BALLYCLAREDM006
The percentage of patients with diabetes, on the register, with a diagnosis of nephropathy (clinical proteinuria) or micro-albuminuria who are currently treated with an ACE-I (or ARBs)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
DM 15 | 2005 | 132 | 146 | 90.4% | |
DM 15 | 2006 | 137 | 148 | 92.6% | |
DM 15 | 2007 | 131 | 146 | 89.7% | |
DM 15 | 2008 | 149 | 165 | 90.3% | |
DM 15 | 2009 | 139 | 156 | 89.1% | |
DM 15 | 2010 | 124 | 140 | 88.6% | |
DM 15 | 2011 | 121 | 129 | 93.8% | |
DM 15 | 2012 | 110 | 118 | 93.2% | |
DM 15 | 2013 | 104 | 110 | 94.5% | |
DM006NI | 2014 | 94 | 100 | 94.0% | |
DM006 | 2015 | 89 | 94 | 94.7% | |
DM006 | 2016 | 79 | 92 | 85.9% | |
DM006 | 2017 | 73 | 86 | 84.9% | |
DM006 | 2018 | 68 | 80 | 85.0% | |
DM006 | 2019 | 66 | 77 | 85.7% | |
DM006 | 2020 | 62 | 75 | 82.7% | |
DM006 | 2021 | 54 | 80 | 67.5% |